InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
2
已披露卖出
0
T+90 胜率
50%
T+90 平均收益
-17.5%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Longitude Capital Partners IV, LLC. Insider active across 2 companies, notably Vera Therapeutics, Inc.. In total, 4 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €15.5m. Activity tracked since 10 February 2022. The latest transaction was filed on 6 February 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Longitude Capital Partners IV, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
1,793,429 股Common StockSEC:0001209191-23-054904:0
1,714,285 股@ US$7.0071.8% 占其流量Class A Common StockSEC:0000899243-23-004349:0
标准退出：2023年5月7日 (T+90)
333,333 股@ US$15.000.12% mcap100.0% 占其流量Class A Common StockSEC:0000899243-22-013598:0
标准退出：2022年5月11日 (T+90)
2,187,504 股Class A Common StockSEC:0001209191-21-033816:0
4 条申报中的 4 条
About Longitude Capital Partners IV, LLC
Longitude Capital Partners IV, LLC is a declarant linked to Vera Therapeutics, Inc. and Lexeo Therapeutics, Inc. No primary role is specified. The declarant has made 5 filings in total, and across the 5 most recent filings tracked here, purchases total 15498212 EUR with no sales, over the period from 2021-05-18 to 2023-11-09.
